(Q50860736)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24526661%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

title

Differential effects of fingolimod on B-cell populations in multiple sclerosis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24526661%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

0 references

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24526661%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

author name string

Masakazu Nakamura

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24526661%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Takako Matsuoka

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24526661%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Sachiko Miyake

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24526661%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Wakiro Sato

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24526661%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Manabu Araki

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24526661%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Tomoko Okamoto

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24526661%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Youwei Lin

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24526661%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Masafumi Ogawa

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24526661%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Miho Murata

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24526661%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Toshimasa Aranami

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24526661%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Takashi Yamamura

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24526661%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

publication date

13 February 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24526661%20AND%20SRC:MED&resulttype=core&format=json

Multiple Sclerosis Journal

7 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24526661%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

volume

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24526661%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24526661%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

page(s)

1371-1380

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24526661%20AND%20SRC:MED&resulttype=core&format=json

Expression of CCR7 in multiple sclerosis: implications for CNS immunity

7 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1177%2F1352458514523496

Sphingosine-1-phosphate and lymphocyte egress from lymphoid organs

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458514523496

Mechanisms of fingolimod's efficacy and adverse effects in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458514523496

A placebo-controlled trial of oral fingolimod in relapsing multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458514523496

Oral fingolimod or intramuscular interferon for relapsing multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458514523496

Th17 central memory T cells are reduced by FTY720 in patients with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458514523496

Tumefactive MS lesions under fingolimod: a case report and literature review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458514523496

Emerging tumefactive multiple sclerosis after switching therapy from natalizumab to fingolimod

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458514523496

Tumefactive multiple sclerosis lesions under fingolimod treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458514523496

Hemorrhaging focal encephalitis under fingolimod (FTY720) treatment: a case report

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458514523496

A case of neuromyelitis optica spectrum disorder developing a fulminant course with multiple white-matter lesions following fingolimod treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458514523496

Development of extensive brain lesions following fingolimod (FTY720) treatment in a patient with neuromyelitis optica spectrum disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458514523496

Clonal expansion and somatic hypermutation of V(H) genes of B cells from cerebrospinal fluid in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458514523496

B-cell depletion with rituximab in relapsing-remitting multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458514523496

Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458514523496

Establishment of a new sensitive assay for anti-human aquaporin-4 antibody in neuromyelitis optica

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458514523496

Interleukin 6 signaling promotes anti-aquaporin 4 autoantibody production from plasmablasts in neuromyelitis optica.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458514523496

Sphingosine 1-phosphate regulates the egress of IgA plasmablasts from Peyer's patches for intestinal IgA responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458514523496

Plasma cell S1P1 expression determines secondary lymphoid organ retention versus bone marrow tropism

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458514523496

Recapitulation of B cell differentiation in the central nervous system of patients with multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458514523496

Memory B cells from a subset of treatment‐naïve relapsing‐remitting multiple sclerosis patients elicit CD4+ T‐cell proliferation and IFN‐γ production in response to myelin basic protein and myelin oligodendrocyte glycoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458514523496

Immune activation and increased IL-21R expression are associated with the loss of memory B cells during HIV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458514523496

Generation of migratory antigen-specific plasma blasts and mobilization of resident plasma cells in a secondary immune response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458514523496

Plasmablasts as migratory IgG-producing cells in the pathogenesis of neuromyelitis optica

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458514523496

Pharmacodynamics of single doses of the novel immunosuppressant FTY720 in stable renal transplant patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458514523496

FTY720 treatment of kidney transplant patients: a differential effect on B cells, naïve T cells, memory T cells and NK cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458514523496

FTY720 therapy exerts differential effects on T cell subsets in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458514523496

Distinct properties of circulating CD8+ T cells in FTY720-treated patients with multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458514523496

B lineage cells in the inflammatory central nervous system environment: migration, maintenance, local antibody production, and therapeutic modulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458514523496

B cells in multiple sclerosis: connecting the dots.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458514523496

Reduction of the peripheral blood CD56(bright) NK lymphocyte subset in FTY720-treated multiple sclerosis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458514523496

21 January 2018

Identifiers

DOI

10.1177/1352458514523496

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24526661%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

1 reference